SCHEMBL1753653

SCHEMBL1753653

CC(=O)OCC1OC(OC(C)=O)C(OS(=O)(=O)C(F)(F)F)C(OC(C)=O)C1OC(C)=O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 11/20 0.55
CYP2D6 P10635 1/20 0.53
THRB P10828 1/20 0.53
HSD17B10 Q99714 1/20 0.53
CA12 O43570 10/20 0.51
CA1 P00915 9/20 0.51
CA9 Q16790 8/20 0.51
TSHR P16473 1/20 0.49
CA4 P22748 2/20 0.48
CA5A P35218 2/20 0.48
CA7 P43166 2/20 0.48
CA5B Q9Y2D0 2/20 0.48
PKM P14618 1/20 0.47
NR3C1 P04150 1/20 0.46
FYN P06241 1/20 0.46
ADRA2A P08913 1/20 0.46
ADORA3 P0DMS8 1/20 0.46
ADRA2B P18089 1/20 0.46
DRD4 P21917 1/20 0.46
DRD3 P35462 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5047747 1.00 CA2 (0.55) CA2CYP2D6THRBHSD17B10CA12
SCHEMBL12128029 1.00 CA2 (0.55) CA2CYP2D6THRBHSD17B10CA12
SCHEMBL543668 1.00 CA2 (0.55) CA2CYP2D6THRBHSD17B10CA12
SCHEMBL543667 1.00 CA2 (0.55) CA2CYP2D6THRBHSD17B10CA12
SCHEMBL16383664 1.00 CA2 (0.55) CA2CYP2D6THRBHSD17B10CA12
SCHEMBL29709529 0.94 CA2 (0.53) CA2CYP2D6THRBHSD17B10CA12
SCHEMBL29709523 0.94 CA2 (0.53) CA2CYP2D6THRBHSD17B10CA12
SCHEMBL29601003 0.90 CYP2D6 (0.55) CA2CYP2D6THRBHSD17B10CA12
SCHEMBL13640512 0.86 CA2 (0.43) CA2CYP2D6THRBHSD17B10CA12
SCHEMBL6322620 0.84 LMNA (0.57) CA2CYP2D6THRBHSD17B10CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105985385-B A kind of integrated fluidic plate synthesis18The method of F-FDG 陕西正泽生物技术有限公司 2018-12-21 CN claimed
CN-118594439-A Preparation equipment of nano material catalyst for toluene hydrogenation reaction 中科威客科技(河南)有限公司 2024-09-06 CN disclosed
CN-116510726-A Atomically dispersed ruthenium nanomaterial catalyst, preparation method thereof and application thereof in toluene hydrogenation reaction 中国科学院金属研究所 2023-08-01 CN disclosed
US-11707538-B2 Methods and devices to generate [F-18]triflyl fluoride and other [F-18] sulfonyl fluorides WASHINGTON UNIVERSITY (US) 2023-07-25 US disclosed
US-11383235-B2 Device and method for microscale chemical reactions THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2022-07-12 US disclosed
US-11306091-B2 Process for producing fluorinated compounds using alcohol solvent having unsaturated hydrocarbon FUTURECHEM CO., LTD (KR) 2022-04-19 US disclosed
US-11242314-B2 Synthesizing pet tracers using [F-18]sulfonyl fluoride as a source of [F-18]fluoride WASHINGTON UNIVERSITY (US) 2022-02-08 US disclosed
US-20200407360-A1 Process for Producing Fluorinated Compounds Using Alcohol Solvent Having Unsaturated Hydrocarbon FUTURECHEM CO., LTD (KR) 2020-12-31 US disclosed
US-20190202820-A1 PROCESS FOR PRODUCING FLUORINATED COMPOUNDS USING ALCOHOL SOLVENT HAVING CARBONYL GROUP FUTURECHEM CO., LTD. (KR) 2019-07-04 US disclosed
CN-105985385-B A kind of integrated fluidic plate synthesis18The method of F-FDG 陕西正泽生物技术有限公司 2018-12-21 CN disclosed
US-9550704-B2 Method for synthesizing radiopharmaceuticals using a cartridge FUTURECHEM CO., LTD. (KR) 2017-01-24 US disclosed
US-9481615-B2 Digital microfluidic platform for radiochemistry THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2016-11-01 US disclosed
CN-105985385-A Method for synthesizing 18F-FDG from integrated circuit board 甘肃圣普诺生物技术有限公司 2016-10-05 CN disclosed
US-20160107951-A1 DIGITAL MICROFLUIDIC PLATFORM FOR RADIOCHEMISTRY THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2016-04-21 US disclosed
US-9193640-B2 Digital microfluidic platform for radiochemistry THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2015-11-24 US disclosed
US-20150232392-A1 METHOD FOR SYNTHESIZING RADIOPHARMACEUTICALS USING A CARTRIDGE FUTURECHEM CO., LTD. (KR) 2015-08-20 US disclosed
US-20150203416-A1 DIGITAL MICROFLUIDIC PLATFORM FOR RADIOCHEMISTRY THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2015-07-23 US disclosed
US-9005544-B2 Digital microfluidic platform for radiochemistry THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2015-04-14 US disclosed
US-8158728-B2 Methods and materials for fabricating microfluidic devices THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2012-04-17 US disclosed
US-20090281250-A1 METHODS AND MATERIALS FOR FABRICATING MICROFLUIDIC DEVICES THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2009-11-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150232392-A1 METHOD FOR SYNTHESIZING RADIOPHARMACEUTICALS USING A CARTRIDGE ADCYAP1R1, PAICS, SSTR5 CA2 4211/4885CYP2D6 1160/4885THRB 1126/4885
US-20200407360-A1 Process for Producing Fluorinated Compounds Using Alcohol Solvent Having Unsaturated Hydrocarbon FASN, CYP2F1, FDFT1 CA2 4751/4885CYP2D6 367/4885THRB 2500/4885
US-11242314-B2 Synthesizing pet tracers using [F-18]sulfonyl fluoride as a source of [F-18]fluoride STX18, GPR119, SLC5A1 CA2 818/4885CYP2D6 1961/4885THRB 1899/4885
US-11306091-B2 Process for producing fluorinated compounds using alcohol solvent having unsaturated hydrocarbon FASN, CYP2F1, FDFT1 CA2 4751/4885CYP2D6 367/4885THRB 2500/4885
US-20190202820-A1 PROCESS FOR PRODUCING FLUORINATED COMPOUNDS USING ALCOHOL SOLVENT HAVING CARBONYL GROUP ADH1A, ADH1C, CYP2E1 CA2 3051/4885CYP2D6 378/4885THRB 2480/4885
US-11707538-B2 Methods and devices to generate [F-18]triflyl fluoride and other [F-18] sulfonyl fluorides STX18, PFAS, FLI1 CA2 1542/4885CYP2D6 1583/4885THRB 114/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.